Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Rhea-AI Summary

Elutia (Nasdaq: ELUT), a drug-eluting biomatrix technologies company, has scheduled its second quarter 2025 financial results release for Thursday, August 14, 2025, after market close.

The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day. Management will be available to discuss the results, with both domestic and international dial-in numbers provided for investor participation.

[]

News Market Reaction – ELUT

+0.49%

+0.49% Session move

In the trading session that priced this news, ELUT gained 0.49%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its second quarter 2025 financial results after market close on Thursday, August 14, 2025. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13754773

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

This press release was published by a CLEAR® Verified individual.

FAQ

When will Elutia (ELUT) release its Q2 2025 earnings?

Elutia will release its Q2 2025 financial results after market close on Thursday, August 14, 2025.

What time is Elutia's Q2 2025 earnings conference call?

Elutia's earnings conference call is scheduled for 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on August 14, 2025.

How can investors access Elutia's Q2 2025 earnings call?

Investors can access the call via webcast on Elutia's investor website, or by phone using 877-407-8029 (US) or 201-689-8029 (International) with Conference ID: 13754773.

Where can I find the webcast of Elutia's Q2 2025 earnings call?

The live and archived webcast will be available on the 'Investors' section of Elutia's website at investors.elutia.com.